Cargando…
Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans?
Several mathematical models to predict tumor growth over time have been developed in the last decades. A central aspect of such models is the interaction of tumor cells with immune effector cells. The Kuznetsov model (Kuznetsov et al. in Bull Math Biol 56(2):295–321, 1994) is the most prominent of t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522842/ https://www.ncbi.nlm.nih.gov/pubmed/36175705 http://dx.doi.org/10.1007/s11538-022-01075-7 |
_version_ | 1784800144838885376 |
---|---|
author | El Wajeh, Mohammad Jung, Falco Bongartz, Dominik Kappatou, Chrysoula Dimitra Ghaffari Laleh, Narmin Mitsos, Alexander Kather, Jakob Nikolas |
author_facet | El Wajeh, Mohammad Jung, Falco Bongartz, Dominik Kappatou, Chrysoula Dimitra Ghaffari Laleh, Narmin Mitsos, Alexander Kather, Jakob Nikolas |
author_sort | El Wajeh, Mohammad |
collection | PubMed |
description | Several mathematical models to predict tumor growth over time have been developed in the last decades. A central aspect of such models is the interaction of tumor cells with immune effector cells. The Kuznetsov model (Kuznetsov et al. in Bull Math Biol 56(2):295–321, 1994) is the most prominent of these models and has been used as a basis for many other related models and theoretical studies. However, none of these models have been validated with large-scale real-world data of human patients treated with cancer immunotherapy. In addition, parameter estimation of these models remains a major bottleneck on the way to model-based and data-driven medical treatment. In this study, we quantitatively fit Kuznetsov’s model to a large dataset of 1472 patients, of which 210 patients have more than six data points, by estimating the model parameters of each patient individually. We also conduct a global practical identifiability analysis for the estimated parameters. We thus demonstrate that several combinations of parameter values could lead to accurate data fitting. This opens the potential for global parameter estimation of the model, in which the values of all or some parameters are fixed for all patients. Furthermore, by omitting the last two or three data points, we show that the model can be extrapolated and predict future tumor dynamics. This paves the way for a more clinically relevant application of mathematical tumor modeling, in which the treatment strategy could be adjusted in advance according to the model’s future predictions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11538-022-01075-7. |
format | Online Article Text |
id | pubmed-9522842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95228422022-10-01 Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? El Wajeh, Mohammad Jung, Falco Bongartz, Dominik Kappatou, Chrysoula Dimitra Ghaffari Laleh, Narmin Mitsos, Alexander Kather, Jakob Nikolas Bull Math Biol Original Article Several mathematical models to predict tumor growth over time have been developed in the last decades. A central aspect of such models is the interaction of tumor cells with immune effector cells. The Kuznetsov model (Kuznetsov et al. in Bull Math Biol 56(2):295–321, 1994) is the most prominent of these models and has been used as a basis for many other related models and theoretical studies. However, none of these models have been validated with large-scale real-world data of human patients treated with cancer immunotherapy. In addition, parameter estimation of these models remains a major bottleneck on the way to model-based and data-driven medical treatment. In this study, we quantitatively fit Kuznetsov’s model to a large dataset of 1472 patients, of which 210 patients have more than six data points, by estimating the model parameters of each patient individually. We also conduct a global practical identifiability analysis for the estimated parameters. We thus demonstrate that several combinations of parameter values could lead to accurate data fitting. This opens the potential for global parameter estimation of the model, in which the values of all or some parameters are fixed for all patients. Furthermore, by omitting the last two or three data points, we show that the model can be extrapolated and predict future tumor dynamics. This paves the way for a more clinically relevant application of mathematical tumor modeling, in which the treatment strategy could be adjusted in advance according to the model’s future predictions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11538-022-01075-7. Springer US 2022-09-29 2022 /pmc/articles/PMC9522842/ /pubmed/36175705 http://dx.doi.org/10.1007/s11538-022-01075-7 Text en © The Author(s) 2022, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article El Wajeh, Mohammad Jung, Falco Bongartz, Dominik Kappatou, Chrysoula Dimitra Ghaffari Laleh, Narmin Mitsos, Alexander Kather, Jakob Nikolas Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? |
title | Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? |
title_full | Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? |
title_fullStr | Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? |
title_full_unstemmed | Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? |
title_short | Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans? |
title_sort | can the kuznetsov model replicate and predict cancer growth in humans? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522842/ https://www.ncbi.nlm.nih.gov/pubmed/36175705 http://dx.doi.org/10.1007/s11538-022-01075-7 |
work_keys_str_mv | AT elwajehmohammad canthekuznetsovmodelreplicateandpredictcancergrowthinhumans AT jungfalco canthekuznetsovmodelreplicateandpredictcancergrowthinhumans AT bongartzdominik canthekuznetsovmodelreplicateandpredictcancergrowthinhumans AT kappatouchrysouladimitra canthekuznetsovmodelreplicateandpredictcancergrowthinhumans AT ghaffarilalehnarmin canthekuznetsovmodelreplicateandpredictcancergrowthinhumans AT mitsosalexander canthekuznetsovmodelreplicateandpredictcancergrowthinhumans AT katherjakobnikolas canthekuznetsovmodelreplicateandpredictcancergrowthinhumans |